Cann Group Limited (ASX:CAN)

Market Cap	6.50M -25.4%
Revenue (ttm)	11.31M -27.1%
Net Income	14.73M
EPS	0.02
Shares Out	1.63B
PE Ratio	0.19
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,222,978
Open	0.0040
Previous Close	0.0040
Day's Range	0.0040 - 0.0040
52-Week Range	0.0030 - 0.0230
Beta	0.14
Analysts	Buy
Price Target	1.12 (+27,900.0%)
Earnings Date	Aug 28, 2026

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CAN

Financial Performance

In fiscal year 2025, Cann Group's revenue was 13.25 million, a decrease of -27.81% compared to the previous year's 18.36 million. Losses were -22.35 million, -56.39% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error